CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | September/October 2025

Building a Tricuspid Program: Multidisciplinary Approaches and Skill Development

Physicians explore the practical aspects of establishing a tricuspid intervention program, including team building, procedural training, reimbursement challenges, and other lessons learned from early adoption of tricuspid technologies.

With Mackram F. Eleid, MD; James McCabe, MD; Firas Zahr, MD; Sameer Gafoor, MD; and Molly Szerlip, MD, FACC, FSCAI

cit | News | November 6, 2021

Medtronic's Intrepid Transfemoral TMVR System Evaluated in Early Feasibility Study

November 6, 2021—Medtronic plc announced the presentation of early data for its self-expanding Intrepid transcatheter mitral valve replacement (TMVR) system in patients with severe, symptomatic mitral regurgitation (MR) via transfemoral access.

cit | News | January 11, 2021

First-In-Human Procedure Performed in Early Feasibility Study of Half Moon's TMVR Device

January 11, 2021—The Foundry announced the successful completion of the first-in-human procedure with the Half Moon Medical transcatheter mitral valve repair technology at Oregon Health and Science University (OHSU) in Portland, Oregon.

cit | News | September 3, 2025

Laza’s AI Heart Model Marks FIH Use in Ultrasound-Guided Cardiac Procedures 

September 3, 2025—Laza Medical, Inc., which is developing artificial intelligence (AI)–powered robotic ultrasound image guidance technology, announced the successful completion of its first software-only human cases at Oregon Health Sciences University Hospital in Portland, Oregon.

Advertisement

Advertisement

cit | News | September 15, 2022

Edwards’ Pascal Precision Transcatheter Valve Repair System Approved by FDA to Treat Degenerative MR

September 15, 2022—Edwards Lifesciences Corporation announced that the company’s Pascal Precision transcatheter valve repair system for transcatheter edge-to-edge repair (TEER) has received FDA approval for the treatment of patients with degenerative mitral regurgitation (DMR).

cit | News | October 26, 2023

Edwards Pascal Precision System Evaluated at 1-Year in CLASP IID RCT and Registry Data

October 26, 2023—Edwards Lifesciences announced 1-year results from the CLASP IID randomized controlled trial (RCT), which is directly comparing two contemporary mitral transcatheter edge-to-edge repair (TEER) therapies, as well as 1-year results from the CLASP IID registry.

cit | Article | September/October 2025

State of the Art in Valvular Disease

By Triston Smith, MD, MGM, and Ranya Sweis, MD, MSc

cit | News | July 18, 2024

Edwards’ Pascal Precision System Approved in Canada to Treat Degenerative Mitral Regurgitation

July 18, 2024—Edwards Lifesciences (Canada) Inc. recently announced Health Canada approval of the company’s Pascal Precision transcatheter valve repair system to treat mitral regurgitation (MR).


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button